Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=17176Vivus, Inc.: VVUS (NASDAQ) WWW.VIVUS.COM About VIVUS VIVUS, Inc. is a pharmaceutical company engaged in the development of innovative therapies for the treatment of quality-of-life disorders in men and women, with a focus on sexual dysfunction. Current development programs target Female S...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=1717638013210mopgcwhttp://www.siliconinvestor.com/readmsg.aspx?msgid=288989045/16/2013 4:58:07 PMmopgcwI added another couple slugs when she hit 10 and change again. getting heavy. need to get back to 15 and 19 and unload those... hope all is well with you.http://www.siliconinvestor.com/readmsg.aspx?msgid=288459354/19/2013 11:17:11 AMBiotech Jim Qsymia prescriptions shipped Month Ended January 31, 2013 16,733 Month Ended February 28, 2013 18,417 Month Ended March 31, 2013 23,812 The above from the 8K report published today. sec.gov http://www.siliconinvestor.com/readmsg.aspx?msgid=288454894/19/2013 8:18:42 AMThe OxVIVUS, Inc. (Nasdaq: VVUS) announced that the U.S. Food and Drug Administration (FDA) has approved its amendment and modification to the Risk Evaluation and Mitigation Strategy (REMS) for Qsymia® (phentermine and topiramate extended-release) capsules CIV. The amendment, submitted in October 2012, allows Qsymia to be d...http://www.siliconinvestor.com/readmsg.aspx?msgid=288432444/18/2013 10:53:00 AMmopgcwVIVUS, Inc. (NASDAQ: VVUS) 5% LOWER; announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) confirmed its October 18, 2012 decision to decline the Marketing Authorization Application (MAA) for Qsiva (phentermine/topiramate ER) for the treatment of obesity in the...http://www.siliconinvestor.com/readmsg.aspx?msgid=287406972/22/2013 11:09:46 AMmopgcwLeerink Swann Resumes Vivus (VVUS) at Outperform, $19-$20 Valuation 7:17 AM 2/6/2013 - StreetInsider Leerink Swann resumes coverage on Vivus (NASDAQ: VVUS) with a Outperform and $19-$20 valuation range. The firm comments, "Bottom Line: Our due diligence points to a significant transformation occurring in the obesi...http://www.siliconinvestor.com/readmsg.aspx?msgid=287106832/6/2013 7:22:22 PMmopgcwVIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX) 10:45 AM 2/4/2013 - StreetInsider VIVUS, Inc. (Nasdaq: VVUS) is lower on the session amid new data for prescriptions of its weight-loss pill, Qsymia. According to Bloomberg Industries, Qsymia prescriptions rose 24 percent to 2...http://www.siliconinvestor.com/readmsg.aspx?msgid=287065052/4/2013 7:24:50 PMmopgcwVivus rises on latest Qsymia prescription report 3:23 PM 1/7/2013 - AcquireMedia NEW YORK -- Shares of Vivus Inc. climbed Monday after the company said prescriptions for its weight loss pill Qsymia surged in late November and December. THE SPARK: Vivus said it shipped about 13,000 orders for Qsymia over the four w...http://www.siliconinvestor.com/readmsg.aspx?msgid=286492631/7/2013 6:56:02 PMtom popeFrom ML/BAC Vivus (VVUS) has been added to the US 1 list today. Today's closing price will be the addition price for the stock. http://www.siliconinvestor.com/readmsg.aspx?msgid=286481051/7/2013 10:44:58 AMtom popeVivus Inc. (VVUS). The company said its obesity drug will now be covered by the U.S. pharmacy benefits manager Express Scripts Holding Co (ESRX) giving more people access to the drug.http://www.siliconinvestor.com/readmsg.aspx?msgid=2861654112/20/2012 8:47:23 AMDewDiligence_on_SIhttp://www.siliconinvestor.com/readmsg.aspx?msgid=2852722411/6/2012 7:02:19 PMBiotech JimAmazed that VVUS has dropped this low, but I decided to pick up a pudgy amount of stock this morning. Looking good so far... How much lower can it go, to a $1B market cap? VVUS will sell this company to a big pharma and then we shall see how these two drugs get marketed and sold. I guess the (to be) purchase price ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2852615011/6/2012 12:48:58 PMmopgcwVIVUS (VVUS) Sinks on Conference Call; 30% of Qsymia Scipts Abandoned Due to Cash Outlay 9:25 AM ET, 11/06/2012 - Street Insider VIVUS (Nasdaq: VVUS) continues to sink following comments on its quarterly conference call Tuesday morning. The following are a few key pieces from VIVUS conference call:3,504 patients are...http://www.siliconinvestor.com/readmsg.aspx?msgid=2852540911/6/2012 9:42:02 AMmopgcw Latest Qsymia Data Shaping Up to Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX) Print. 2:18 PM 10/31/2012 - StreetInsider VIVUS (Nasdaq: VVUS) shares continue to be pressured Wednesday amid a note that its obesity pill may have fad-like qualities. Cowen's Simos Simeonidis said today that the late...http://www.siliconinvestor.com/readmsg.aspx?msgid=2851284210/31/2012 7:27:56 PMBiotech JimThe EU also feels burned by Mediator, the product of a private French company - now in a world of hurt over this now discontinued drug. M had fenfluramine-like side effects. This agent was approved for severe diabetes due to its reported effects on glycemic control and insulin resistance but the challenge is that the...http://www.siliconinvestor.com/readmsg.aspx?msgid=2849050310/22/2012 1:43:56 PMscaram(o)ucheDidn't verify such, but today's Acquire Media report indicated that prescriptions have started to flow through the "newly-added Express Scripts channel". Europe... 1. setting the european stage..... thalidomide? FDA never licensed it. 2. Obesity A. Sanofi's insane blunder, rimonabant? FDA never licensed it. B...http://www.siliconinvestor.com/readmsg.aspx?msgid=2849039310/22/2012 1:02:38 PMtom pope Shares of Vivus Inc. fell after an analyst said Wall Street may be over-estimating gains from initial sales of the drug developer's obesity treatment Qsymia.http://www.siliconinvestor.com/readmsg.aspx?msgid=2848273710/18/2012 3:05:47 PMtom popeDon't own any VVUS,but the big drop caught my eye. SA Vivus ( VVUS) shares are down sharply (almost 3% to $20.81) in pre-market trading as the company has expressed worry that its anti obesity drug Qsiva (the EU version of Qsymia) will not gain approval in Europe via the European Medicines Agency. The company ba...http://www.siliconinvestor.com/readmsg.aspx?msgid=284243549/21/2012 10:14:35 AMKelly AlbertoChromadex’ pterostilbene human clinical study results are due to be released on September 20, 2012. Will a positive result create an interest for takeover by its peers like VVUS or ARNA? Are there any synergies? Will VVUS or ARNA lose a big pie of their market share because of Chromadex’ bluescience range of products? ...http://www.siliconinvestor.com/readmsg.aspx?msgid=284058569/13/2012 2:00:17 PMshohelkhanAs vivus offers this type treatment where ChromaDex taken a whole market business.http://www.siliconinvestor.com/readmsg.aspx?msgid=283917559/7/2012 11:15:13 AMDewDiligence_on_SIBelviq is a new drug with solid patent protection on the composition of matter; hence, no one will be able to market a generic version for a long time. Qsymia, on the other hand, is a combination of two older drugs whose only protection is formulation and method-of-use patents that are less likely to stand up to sc...http://www.siliconinvestor.com/readmsg.aspx?msgid=283691838/29/2012 9:44:29 AMSam1832Dew, Could you expand a bit further on the meaning of your two previous posts? Qsymia is indeed listed in the FDA's Orange Book, but so is Belviq. What distinguishes these two very similar looking filings in the Orange Book?http://www.siliconinvestor.com/readmsg.aspx?msgid=283678008/28/2012 5:18:14 PMDewDiligence_on_SIQsymia does not get NCE status—expect Paragarph-IV challenges soon: investorshub.advfn.com http://www.siliconinvestor.com/readmsg.aspx?msgid=283511788/21/2012 4:32:05 PMDewDiligence_on_SIA key point that some have overlooked is that the JNJ patent in question is not listed in the Orange Book.http://www.siliconinvestor.com/readmsg.aspx?msgid=283072218/1/2012 12:21:08 PMIRWIN JAMES FRANKELArticle on the VVUS patent situation: seekingalpha.com  Author: seekingalpha.com http://www.siliconinvestor.com/readmsg.aspx?msgid=283051807/31/2012 3:24:52 PMSanDiegoBiotechA team of British researchers has completed a detailed analysis of the clinical trials of the two approved diet pills (Belviq, Qnexa/Qsymia) and Contrave, and published their results in the July issue of Neuropharmacology. They wrote, “In terms of weight-loss and metabolic benefits, Qnexa [Qsymia ] is the leader.” sa...http://www.siliconinvestor.com/readmsg.aspx?msgid=282831517/21/2012 8:21:48 PMMark3000Fast Money web extra VVUS was on tonights web extra with guy adami doing the commentary, here is the video clip: marklexusblogpage.blogspot.com http://www.siliconinvestor.com/readmsg.aspx?msgid=282765577/18/2012 11:05:01 PMscaram(o)uche>> obviously nervous longs << Seems like nine of ten Twits were clamoring to call it a "sell-on-news". This new guy at thestreet is particularly irritating and uninformed. So, I'd say "nervous longs" plus about a million twits who each went short, 25-50 shares. Nice call, Jim. Enjoy that party!! (old guys get t...http://www.siliconinvestor.com/readmsg.aspx?msgid=282736467/17/2012 8:42:55 PMBiotech JimI always did like track and field. I put the shot in high school and barely hit 50 ft. That made me happy as I improved by about 6 ft my senior year. My most dramatic and lucky accomplishment though was when I ran a single 440 yd race my senior year, and had a time of 59.8 seconds. I thought I was going to lose m...http://www.siliconinvestor.com/readmsg.aspx?msgid=282735677/17/2012 7:59:53 PMscaram(o)ucheNo, had not seen the trademark before today. But Feuerstein had gotten the "no surprise" word out by 1 p.m. Eastern or earlier, and that was part of the ease in assessing the staying power, USA Today bit. Doing good, Jim. Out jumping, "sprinting", and, as of the next meet, throwing (shot put, a realm where you'd get ...http://www.siliconinvestor.com/readmsg.aspx?msgid=282735007/17/2012 7:32:04 PMdr.praveenhttp://www.siliconinvestor.com/readmsg.aspx?msgid=282734587/17/2012 7:15:23 PMBiotech JimQsymia? Is that the first time you heard that name? Never heard of it until I saw the USA Today picture. How is it going Rick? BJhttp://www.siliconinvestor.com/readmsg.aspx?msgid=282732567/17/2012 5:12:40 PMscaram(o)ucheDid USA Today mess up and blow an embargo? Was that an orchestrated bear raid this morning? Drama, drama, drama!!! (note that there are only two dosage forms shown in the USA Today photo....)http://www.siliconinvestor.com/readmsg.aspx?msgid=282726717/17/2012 1:16:29 PMMark30006/22/2012 Options Action trade did you catch the options action web extra.. scott has a trade for VVUS in response to a viewer email.. dont really like the trade but here it is, the video and some comments by me: [graphic]http://cnbcoptionsactionstrades.blogspot.com/2012/06/options-action-web-extra-trade-vvus.htmlhttp://www.siliconinvestor.com/readmsg.aspx?msgid=282233506/23/2012 12:17:21 AMscaram(o)ucheHey, Doc. Yeah, saw those as they went through..... most here know how I feel about 10b5-1 plans and development-stage companies, but planned sales aren't worth worrying about, imo and current context. Best! Rickhttp://www.siliconinvestor.com/readmsg.aspx?msgid=282130486/18/2012 10:13:46 AMdr.praveena $1.9 million sale by two insiders at Vivus Inc. (VVUS), that is a biopharmaceutical company developing therapeutic products to address unmet medical needs in obesity, diabetes and sexual health http://sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=vvus&filenum=&State=&Country=&SIC=&owner=include&Find=Find+Compani...http://www.siliconinvestor.com/readmsg.aspx?msgid=282115346/17/2012 10:15:54 AMscaram(o)uche>> any color on the meeting or voting besides the final tally? << Thought about it more.... felt like three of the four "no" votes resulted from concern over adenoma frequency/time to origin, and the fourth was insufficient efficacy/downside ratio. It was a waltz, otherwise. And there wasn't THAT much discussion re...http://www.siliconinvestor.com/readmsg.aspx?msgid=281391735/11/2012 1:22:57 PMscaram(o)uche>> any color on the meeting or voting besides the final tally? << Nissen wasn't there. ;-) Easy meeting for Arena............ magnificent in presenting their case around responder analysis, hitting hard at safety. Three of the four "no" votes popped out of nowhere. Even I would have voted yes. Hope you're lov...http://www.siliconinvestor.com/readmsg.aspx?msgid=281387295/11/2012 10:47:01 AMBiotech Jim<Not just talking my stake, effective competing therapies may actually be complementary re. long-term sales.> I fully agree Rick, and have thought all along that having 2 such drugs will be good once one hits that 'plateau' so as to provide a different mechanistic approach. Congrats to all ARNA longs. Alas, not me....http://www.siliconinvestor.com/readmsg.aspx?msgid=281384175/11/2012 8:59:15 AMsjemmerihttp://www.siliconinvestor.com/readmsg.aspx?msgid=281372235/10/2012 4:28:31 PMDewDiligence_on_SI>…effective competing therapies may actually be complementary re. long-term sales.< Do you mean that they are complementary in the sense that each drug provides a patient pool for potential switches to the other?http://www.siliconinvestor.com/readmsg.aspx?msgid=281372065/10/2012 4:23:49 PMscaram(o)ucheFor durable weight loss and re. today's 18-4 vote backing lorca...... [graphic]Message 27138913 Not just talking my stake, effective competing therapies may actually be complementary re. long-term sales.http://www.siliconinvestor.com/readmsg.aspx?msgid=281371665/10/2012 4:15:28 PMdr.praveenhttp://www.siliconinvestor.com/readmsg.aspx?msgid=281150084/30/2012 10:39:30 AMscaram(o)uche>> If they reopen this sucker today (before consensus forms), it's going to be sitting ducks. << Pfffffffffffffffffffffffbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbt! There's more volatility in my grandma's rocker.http://www.siliconinvestor.com/readmsg.aspx?msgid=281113364/27/2012 3:50:09 PMscaram(o)ucheI'll try to trade ANY move that seems to have greed behind it rather than consensus OR rationale. :-) Could mean that I'd bail with an eye to reloading, could mean a double down. Just out, resumes at 3:40. Congrats, Jim!! Thanks, VIVUS team! Rick http://www.siliconinvestor.com/readmsg.aspx?msgid=281112914/27/2012 3:35:02 PMsjemmeriARNA up 20 % o 29 million shares in sympathy? Daytraders don't even realize that the VVUS news has absolutely nothing to do with anything remotely related to ARNA??http://www.siliconinvestor.com/readmsg.aspx?msgid=281112224/27/2012 3:17:50 PMBiotech Jimhttp://www.siliconinvestor.com/readmsg.aspx?msgid=281111484/27/2012 2:53:58 PMscaram(o)ucheIf they reopen this sucker today (before consensus forms), it's going to be sitting ducks.http://www.siliconinvestor.com/readmsg.aspx?msgid=281110504/27/2012 2:20:11 PMscaram(o)uchehttp://www.siliconinvestor.com/readmsg.aspx?msgid=281110254/27/2012 2:12:12 PMscaram(o)ucheavanafil.... as everyone knows by now.... notice of approval, "Stendra", was posted at FDA website and then yanked away. so, assuming that all is well during this trading halt.... "Stendra" is a good trade name, no?http://www.siliconinvestor.com/readmsg.aspx?msgid=281110034/27/2012 2:03:11 PM